PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.
Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's designation as the sole
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31)
Could each of you please provide a little bit of background about yourself?
(01:18)
Let's start with a general definition of primary ciliary dyskinesia (PCD) for our audience.
(02:21)
PCD is rare. Dr. Maleszewski, can you talk about the implications of that?
(02:39)
What is the current state of PCD diagnosis in the U.S. and globally, and what are the implications for patient care?
(03:37)
Can you say a bit more about Mayo Clinic's diagnostic approach to PCD?
(05:16)
Mayo Clinic is the first and only diagnostic center of excellence accredited by the primary PCD foundation. What is the significance of that?
(07:01)
Can you expand upon future plans for PCD diagnosis at Mayo Clinic?